Synthesis and bioactivity of bis-steroidal pyrazine 23-deoxy-25-epi ritterostatin GN1N

[Display omitted] •Synthesis of ritterostatin, a hybrid analog of ritterazine and cephalostatin.•Ritterostatin synthesis involves reductive/oxidative modifications of hecogenin acetate.•Evaluation of the impact of C23 hydroxyl group on bioactivity of ritterostatin. Cephalostatins, ritterazines and t...

Full description

Saved in:
Bibliographic Details
Published in:Steroids 2017-10, Vol.126, p.74-78
Main Authors: Kumar, Rayala Naveen, Lee, Seongmin
Format: Article
Language:English
Subjects:
Anticancer steroids
Cephalostatin
Ritterazine
Steroidal alkaloids
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c260t-717a6af850d8a42c4d3791fe30441ed28ebb86b06d36f05cce69837871f87dad3
cites cdi_FETCH-LOGICAL-c260t-717a6af850d8a42c4d3791fe30441ed28ebb86b06d36f05cce69837871f87dad3
container_end_page 78
container_issue
container_start_page 74
container_title Steroids
container_volume 126
creator Kumar, Rayala Naveen
Lee, Seongmin
description [Display omitted] •Synthesis of ritterostatin, a hybrid analog of ritterazine and cephalostatin.•Ritterostatin synthesis involves reductive/oxidative modifications of hecogenin acetate.•Evaluation of the impact of C23 hydroxyl group on bioactivity of ritterostatin. Cephalostatins, ritterazines and their hybrid bis-steroidal pyrazine analogs such as 25-epi-rittereostatin GN1N show unusually high potency against a wide range of cancer cell lines. Herein, we report the synthesis and bioactivity of 23-deoxy-25-epi ritterostatin GN1N, which lacks the 23-hydroxyl group of 25-epi rittereostatin GN1N. The less oxygenated bis-steroidal pyrazine was ∼50- to 1000-fold less potent than 25-epi ritterostatin GN1N, highlighting the importance of the 23-hydroxyl group for the antiproliferative activity of the cephalostatin/ritterazine class of drugs.
doi_str_mv 10.1016/j.steroids.2017.07.008
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1926686359</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0039128X17301307</els_id><sourcerecordid>1926686359</sourcerecordid><originalsourceid>FETCH-LOGICAL-c260t-717a6af850d8a42c4d3791fe30441ed28ebb86b06d36f05cce69837871f87dad3</originalsourceid><addsrcrecordid>eNqFkE9LAzEQxYMoWKtfQfboJXWSdJPsTSlahVIP_sFbSJNZTGl3a5IW10_vlupZeDAMvPeY-RFyyWDEgMnr5ShljG3wacSBqRH0An1EBkwrTUst1TEZAIiKMq7fT8lZSksAkKLiA_L23DX5A1NIhW18sQitdTnsQu6Ktu7XRH_L7arYdNF-hwYLLqjH9qujvKS4CUUMeW9K2ebQFNM5m5-Tk9quEl78ziF5vb97mTzQ2dP0cXI7o45LyFQxZaWtdQle2zF3Yy9UxWoUMB4z9FzjYqHlAqQXsobSOZSVFkorVmvlrRdDcnXo3cT2c4spm3VIDlcr22C7TYZVXEotRVn1Vnmwuv7SFLE2mxjWNnaGgdmDNEvzB9LsQRroBboP3hyC2D-yCxhNcgEbhz5EdNn4NvxX8QN4t4Bv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1926686359</pqid></control><display><type>article</type><title>Synthesis and bioactivity of bis-steroidal pyrazine 23-deoxy-25-epi ritterostatin GN1N</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Kumar, Rayala Naveen ; Lee, Seongmin</creator><creatorcontrib>Kumar, Rayala Naveen ; Lee, Seongmin</creatorcontrib><description>[Display omitted] •Synthesis of ritterostatin, a hybrid analog of ritterazine and cephalostatin.•Ritterostatin synthesis involves reductive/oxidative modifications of hecogenin acetate.•Evaluation of the impact of C23 hydroxyl group on bioactivity of ritterostatin. Cephalostatins, ritterazines and their hybrid bis-steroidal pyrazine analogs such as 25-epi-rittereostatin GN1N show unusually high potency against a wide range of cancer cell lines. Herein, we report the synthesis and bioactivity of 23-deoxy-25-epi ritterostatin GN1N, which lacks the 23-hydroxyl group of 25-epi rittereostatin GN1N. The less oxygenated bis-steroidal pyrazine was ∼50- to 1000-fold less potent than 25-epi ritterostatin GN1N, highlighting the importance of the 23-hydroxyl group for the antiproliferative activity of the cephalostatin/ritterazine class of drugs.</description><identifier>ISSN: 0039-128X</identifier><identifier>EISSN: 1878-5867</identifier><identifier>DOI: 10.1016/j.steroids.2017.07.008</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Anticancer steroids ; Cephalostatin ; Ritterazine ; Steroidal alkaloids</subject><ispartof>Steroids, 2017-10, Vol.126, p.74-78</ispartof><rights>2017 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c260t-717a6af850d8a42c4d3791fe30441ed28ebb86b06d36f05cce69837871f87dad3</citedby><cites>FETCH-LOGICAL-c260t-717a6af850d8a42c4d3791fe30441ed28ebb86b06d36f05cce69837871f87dad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Kumar, Rayala Naveen</creatorcontrib><creatorcontrib>Lee, Seongmin</creatorcontrib><title>Synthesis and bioactivity of bis-steroidal pyrazine 23-deoxy-25-epi ritterostatin GN1N</title><title>Steroids</title><description>[Display omitted] •Synthesis of ritterostatin, a hybrid analog of ritterazine and cephalostatin.•Ritterostatin synthesis involves reductive/oxidative modifications of hecogenin acetate.•Evaluation of the impact of C23 hydroxyl group on bioactivity of ritterostatin. Cephalostatins, ritterazines and their hybrid bis-steroidal pyrazine analogs such as 25-epi-rittereostatin GN1N show unusually high potency against a wide range of cancer cell lines. Herein, we report the synthesis and bioactivity of 23-deoxy-25-epi ritterostatin GN1N, which lacks the 23-hydroxyl group of 25-epi rittereostatin GN1N. The less oxygenated bis-steroidal pyrazine was ∼50- to 1000-fold less potent than 25-epi ritterostatin GN1N, highlighting the importance of the 23-hydroxyl group for the antiproliferative activity of the cephalostatin/ritterazine class of drugs.</description><subject>Anticancer steroids</subject><subject>Cephalostatin</subject><subject>Ritterazine</subject><subject>Steroidal alkaloids</subject><issn>0039-128X</issn><issn>1878-5867</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqFkE9LAzEQxYMoWKtfQfboJXWSdJPsTSlahVIP_sFbSJNZTGl3a5IW10_vlupZeDAMvPeY-RFyyWDEgMnr5ShljG3wacSBqRH0An1EBkwrTUst1TEZAIiKMq7fT8lZSksAkKLiA_L23DX5A1NIhW18sQitdTnsQu6Ktu7XRH_L7arYdNF-hwYLLqjH9qujvKS4CUUMeW9K2ebQFNM5m5-Tk9quEl78ziF5vb97mTzQ2dP0cXI7o45LyFQxZaWtdQle2zF3Yy9UxWoUMB4z9FzjYqHlAqQXsobSOZSVFkorVmvlrRdDcnXo3cT2c4spm3VIDlcr22C7TYZVXEotRVn1Vnmwuv7SFLE2mxjWNnaGgdmDNEvzB9LsQRroBboP3hyC2D-yCxhNcgEbhz5EdNn4NvxX8QN4t4Bv</recordid><startdate>20171001</startdate><enddate>20171001</enddate><creator>Kumar, Rayala Naveen</creator><creator>Lee, Seongmin</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20171001</creationdate><title>Synthesis and bioactivity of bis-steroidal pyrazine 23-deoxy-25-epi ritterostatin GN1N</title><author>Kumar, Rayala Naveen ; Lee, Seongmin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c260t-717a6af850d8a42c4d3791fe30441ed28ebb86b06d36f05cce69837871f87dad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Anticancer steroids</topic><topic>Cephalostatin</topic><topic>Ritterazine</topic><topic>Steroidal alkaloids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumar, Rayala Naveen</creatorcontrib><creatorcontrib>Lee, Seongmin</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Steroids</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumar, Rayala Naveen</au><au>Lee, Seongmin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and bioactivity of bis-steroidal pyrazine 23-deoxy-25-epi ritterostatin GN1N</atitle><jtitle>Steroids</jtitle><date>2017-10-01</date><risdate>2017</risdate><volume>126</volume><spage>74</spage><epage>78</epage><pages>74-78</pages><issn>0039-128X</issn><eissn>1878-5867</eissn><abstract>[Display omitted] •Synthesis of ritterostatin, a hybrid analog of ritterazine and cephalostatin.•Ritterostatin synthesis involves reductive/oxidative modifications of hecogenin acetate.•Evaluation of the impact of C23 hydroxyl group on bioactivity of ritterostatin. Cephalostatins, ritterazines and their hybrid bis-steroidal pyrazine analogs such as 25-epi-rittereostatin GN1N show unusually high potency against a wide range of cancer cell lines. Herein, we report the synthesis and bioactivity of 23-deoxy-25-epi ritterostatin GN1N, which lacks the 23-hydroxyl group of 25-epi rittereostatin GN1N. The less oxygenated bis-steroidal pyrazine was ∼50- to 1000-fold less potent than 25-epi ritterostatin GN1N, highlighting the importance of the 23-hydroxyl group for the antiproliferative activity of the cephalostatin/ritterazine class of drugs.</abstract><pub>Elsevier Inc</pub><doi>10.1016/j.steroids.2017.07.008</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0039-128X
ispartof Steroids, 2017-10, Vol.126, p.74-78
issn 0039-128X
1878-5867
language eng
recordid cdi_proquest_miscellaneous_1926686359
source ScienceDirect Freedom Collection 2022-2024
subjects Anticancer steroids
Cephalostatin
Ritterazine
Steroidal alkaloids
title Synthesis and bioactivity of bis-steroidal pyrazine 23-deoxy-25-epi ritterostatin GN1N
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A13%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20bioactivity%20of%20bis-steroidal%20pyrazine%2023-deoxy-25-epi%20ritterostatin%20GN1N&rft.jtitle=Steroids&rft.au=Kumar,%20Rayala%20Naveen&rft.date=2017-10-01&rft.volume=126&rft.spage=74&rft.epage=78&rft.pages=74-78&rft.issn=0039-128X&rft.eissn=1878-5867&rft_id=info:doi/10.1016/j.steroids.2017.07.008&rft_dat=%3Cproquest_cross%3E1926686359%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c260t-717a6af850d8a42c4d3791fe30441ed28ebb86b06d36f05cce69837871f87dad3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1926686359&rft_id=info:pmid/&rfr_iscdi=true